Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT + NK cells may be related to poor outcome in acute myeloid leukemia-Reference-Cited by-同舟云学术

Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT + NK cells may be related to poor outcome in acute myeloid leukemia

Published:2021-11-23 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Zeng Xiangbo¹²^ORCID,Yao Danlin¹²,Liu Lian¹²,Zhang Yikai¹²,Lai Jing²,Zhong Jun²,Zha Xianfeng³,Lu Yuhong²,Jin Zhenyi¹,Chen Shaohua¹,Li Yangqiu¹²^ORCID,Xu Ling¹²^ORCID

Affiliation:

1. Key Laboratory for Regenerative Medicine of Ministry of Education; Institute of Hematology, School of Medicine; Jinan University Guangzhou 510632 China

2. Department of Hematology; First Affiliated Hospital Guangzhou Medical University Guangzhou 510632 China

3. Department of clinical laboratory, First Affiliated Hospital Jinan University Guangzhou 510632 China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13723

Reference40 articles.

1. A review of FDA‐approved acute myeloid leukemia therapies beyond ‘7+3’;Bazinet A;Expert Rev Hematol,2021

2. Selecting initial treatment of acute myeloid leukaemia in older adults;Podoltsev NA;Blood Rev,2017

3. Higher frequency of the CTLA‐4(+) LAG‐3(+) T‐cell subset in patients with newly diagnosed acute myeloid leukemia;Chen Y;Asia Pac J Clin Oncol,2020

4. Hypomethylating agents for elderly patients with acute myeloid leukemia: A PRISMA systematic review and meta‐analysis;Zhang RJ;Eur Rev Med Pharmacol Sci,2021

5. Novel treatment paradigms in acute myeloid leukemia;Khanal N;Clin Pharmacol Ther,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune‐dysregulation harnessing in myeloid neoplasms;Cancer Medicine;2024-09

2. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

3. The role of KLRG1: a novel biomarker and new therapeutic target;Cell Communication and Signaling;2024-06-19

4. The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia;Cell Communication and Signaling;2024-01-22

5. Targeting TIGIT for cancer immunotherapy: recent advances and future directions;Biomarker Research;2024-01-16